Multigénový test na hereditárne (dedičné) nádory (gény BRCA sú súčasťou panelu)
HerediGENE® je multigénový diagnostický test s certifikáciou CE-IVD, určený na analýzu hereditárnych nádorových syndrómov. Test analyzuje 83 génov, vrátane BRCA1 a BRCA2, ktoré sú spojené so zvýšeným rizikom vzniku karcinómu prsníka, ovariálneho karcinómu, karcinómu prostaty, kolorektálneho karcinómu a ďalších typov dedičných nádorov.
Test poskytuje:| Cancer Types |
|---|
| Prsník, vaječníky, pankreas, prostata, endometrium, hrubé črevo, žalúdok, gastrointestinálne stromálne nádory (GIST), štítna žľaza, prištítne telieska, obličky, leiomyomatóza, polypóza, melanóm, retinoblastóm, feochromocytóm, paragangliómy, Wilmsov tumor, sarkómy. |
| Cancer Syndromes |
|---|
| Hereditárny syndróm karcinómu prsníka a ovárií, Lynchov syndróm, Cowdenov syndróm, Li-Fraumeni syndróm, Peutz–Jeghersov syndróm, familiárna adenomatózna polypóza, Von Hippel–Lindauov syndróm, syndróm mnohočetnej endokrinnej neoplázie, ataxia-telangiektázia, Fanconiho anémia, Noonanov syndróm, Bloomov syndróm, Birt-Hogg-Dubého syndróm, Nijmegenov syndróm, neurofibromatóza, hereditárna pankreatitída, tuberózna skleróza. |
Jedinci, ktorí nesú dedičné patogénne varianty, majú zvýšené riziko vzniku určitých typov nádorových ochorení. Genetický profil preto poskytuje kľúčové informácie podporujúce terapeutické rozhodovanie a klinické riadenie starostlivosti o pacientov aj ich rodiny.
Panel HerediGENE® analyzuje 83 génov podieľajúcich sa na nádorovej predispozícii, z ktorých 17 je asociovaných s dráhou homologickej rekombinácie (HR – Homologous Recombination).
Tento komplexný génový panel:
Test HerediGENE® je certifikovaný diagnostický test (CE-IVD) navrhnutý tak, aby zabezpečil maximálnu analytickú senzitivitu a presnosť.
| Colon | Breast | Pancreas | Ovarian | Gastric | Melanoma | Endometrial | Endocrine | Renal | Prostate | Rare Tumors | Thyroid | HRD | Súvisiace syndrómy | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genes | ||||||||||||||
| APC | APC | APC | APC | APC | Familial adenomatous polyposis | |||||||||
| ATM | ATM | ATM | ATM | ATM | ATM | Breast cancer, Ataxia-Telangiectasia | ||||||||
| AXIN2 | AXIN2 | Colorectal cancer | ||||||||||||
| ATRX | Alpha-thalassemia myelodysplasia syndrome | |||||||||||||
| BAP1 | BAP1 | BAP1 | BAP1 | BAP1 | Colorectal cancer, Uveal Melanoma | |||||||||
| BARD1 | BARD1 | BARD1 | BARD1 | BARD1 | Colorectal cancer, Uveal Melanoma | |||||||||
| BLM | BLM | BLM | Bloom syndrome | |||||||||||
| BMPR1A* | BMPR1A | BMPR1A | Polyposis, juvenile intestinal | |||||||||||
| BRAF* | LEOPARD syndrome, Noonan syndrome | |||||||||||||
| BRCA1* | BRCA1 | BRCA1 | BRCA1 | BRCA1 | BRCA1 | BRCA1 | Pancreatic cancer, Breast-ovarian cancer, familial, Fanconi anemia | |||||||
| BRCA2 | BRCA2 | BRCA2 | BRCA2 | BRCA2 | BRCA2 | BRCA2 | Fanconi anemia, Medulloblastoma, Glioma susceptibility, Pancreatic cancer, Wilms tumor, Breast-ovarian cancer, familial | |||||||
| BRIP1 | BRIP1 | BRIP1 | BRIP1 | Fanconi anemia, Breast cancer | ||||||||||
| CDH1 | CDH1 | CDH1 | Hereditary diffuse gastric cancer | |||||||||||
| CDK4 | CDK4 | Melanoma, cutaneous malignant | ||||||||||||
| CDKN1C | CDKN1C | CDKN1C | Beckwith-Wiedemann syndrome, Wilms Tumors, Neuroblastoma, Hepatoblastoma | |||||||||||
| CDKN2A | CDKN2A | CDKN2A | Melanoma, familial, Melanoma-pancreatic cancer syndrome | |||||||||||
| CHEK2* | CHEK2 | CHEK2 | CHEK2 | Breast cancer | ||||||||||
| CTR9 | CTR9 | CTR9 | CTR9 | Myeloid Malignancies, Wilms Tumor | ||||||||||
| EGLN1 | EGLN1 | EGLN1 | Paraganglioma or Pheochromocytoma | |||||||||||
| EGLN2 | EGLN2 | EGLN2 | Paraganglioma or Pheochromocytoma | |||||||||||
| EPAS1 | EPAS1 | EPAS1 | Paraganglioma or Pheochromocytoma | |||||||||||
| EPCAM | EPCAM | EPCAM | EPCAM | EPCAM | Colorectal cancer, hereditary nonpolyposis | |||||||||
| EXT1 | EXT1 | Multiple cartilagenious exostoses 1 | ||||||||||||
| EXT2 | EXT2 | Multiple cartilagenious exostoses 2 | ||||||||||||
| FGFR1 | ||||||||||||||
| FH | FH | FH | Hereditary leiomyomatosis and renal cell cancer | |||||||||||
| FLCN | FLCN | FLCN | Birt-Hogg-Dube syndrome, | |||||||||||
| GREM1 | GREM1 | Hereditary mixed polyposis syndrome | ||||||||||||
| H3-3A | ||||||||||||||
| HRAS | HRAS | Costello syndrome | ||||||||||||
| IDH2 | ||||||||||||||
| KIF1B | KIF1B | KIF1B | Pheochromocytoma, Neuroblastoma | |||||||||||
| KIT | ||||||||||||||
| KMT2D | KMT2D | KMT2D | Neuroblastoma, Wilms Tumor | |||||||||||
| MAX | MAX | MAX | Pheochromocytoma | |||||||||||
| MDH2 | MDH2 | MDH2 | Paraganglioma or Pheochromocytoma | |||||||||||
| MEN1 | MEN1 | MEN1 | Hyperparathyroidism, Multiple endocrine neoplasia | |||||||||||
| MERTK | ||||||||||||||
| MET | MET | MET | Renal cell carcinoma | |||||||||||
| MLH1 | MLH1 | MLH1 | MLH1 | MLH1 | MLH1 | Lynch Syndrome | ||||||||
| MRE11A | MRE11A | Ataxia-telangiectasia-like disorder-1 | ||||||||||||
| MSH2 | MSH2 | MSH2 | MSH2 | MSH2 | MSH2 | Lynch Syndrome | ||||||||
| MSH3 | MSH3 | Colorectal adenomatous polyposis | ||||||||||||
| MSH6 | MSH6 | MSH6 | MSH6 | MSH6 | MSH6 | Lynch Syndrome | ||||||||
| MUTYH | MUTYH-asociovaná polypóza | |||||||||||||
| MTAP | ||||||||||||||
| MUTYH | MUTYH | Familial adenomatous polyposis, Colorectal adenomatous polyposis | ||||||||||||
| NBN | NBN | Breast cancer, Nijmegen breakage syndrome | ||||||||||||
| NF1* | NF1 | NF1 | NF1 | NF1 | NF1 | Neurofibromatosis, Neurofibromatosis-Noonan syndrome | ||||||||
| NF2 | NF2 | Neurofibromatosis | ||||||||||||
| NTHL1 | Adenomatózna polypóza (recesívna) | |||||||||||||
| PALB2 | PALB2 | PALB2 | Adenomatózna polypóza (recesívna) | |||||||||||
| NTHL1 | NTHL1 | NTHL1 | Familial adenomatous polyposis 3 | |||||||||||
| PALB2 | PALB2 | PALB2 | PALB2 | Fanconi anemia, Pancreatic cancer, Breast cancer | ||||||||||
| PDGFRA | PDGFRA | PDGFRA | Gastrointestinal stromal tumor | |||||||||||
| PMS2 | PMS2 | PMS2 | PMS2 | PMS2 | PMS2 | Lynch Syndrome | ||||||||
| POLD1 | POLD1 | POLD1 | Colorectal cancer | |||||||||||
| POLE | POLE | POLE | Colorectal cancer | |||||||||||
| PRSS1 | PRSS1 | Hereditary Pancreatitis | ||||||||||||
| PTEN* | PTEN | PTEN | PTEN | PTEN | PTEN | PTEN | Cowden syndrome | |||||||
| RAD50 | RAD50 | RAD50 | Nijmegen breakage syndrome like disorder (recessive) | |||||||||||
| RAD51C | RAD51C | RAD51C | RAD51C | Fanconi anemia, Breast-ovarian cancer | ||||||||||
| RAD51D | RAD51D | RAD51D | RAD51D | Breast-ovarian cancer | ||||||||||
| RB1 | RB1 | Retinoblastoma | ||||||||||||
| RECQL4 | RECQL4 | Skin Cancer, Osteosarcoma | ||||||||||||
| REST | REST | REST | Fibromatosis, Wilms tumor | |||||||||||
| RET | RET | RET | RET | RET | Pheochromocytoma, Medullary thyroid carcinoma, Multiple endocrine neoplasia | |||||||||
| RNF43 | RNF43 | Polyposis cancer syndrome | ||||||||||||
| SDHA* | SDHA | SDHA | SDHA | SDHA | Gastrointestinal stromal tumor, Paragangliomas | |||||||||
| SDHAF2 | SDHAF2 | SDHAF2 | Paragangliomas | |||||||||||
| SDHB | SDHB | SDHB | SDHB | SDHB | Paraganglioma and gastric stromal sarcoma, Pheochromocytoma, Gastrointestinal stromal tumor, Paragangliomas, Cowden-like syndrome | |||||||||
| SDHC | SDHC | SDHC | SDHC | SDHC | Paraganglioma and gastric stromal sarcoma, Gastrointestinal stromal tumor, Paragangliomas | |||||||||
| SDHD# | SDHD | SDHD | SDHD | SDHD | Paraganglioma and gastric stromal sarcoma, Pheochromocytoma, Paragangliomas, Carcinoid tumors, intestinal, Cowden syndrome | |||||||||
| SLX4 | SLX4 | Fanconi anemia | ||||||||||||
| SMAD4 | SMAD4 | SMAD4 | Juvenile polyposis | |||||||||||
| SPINK1 | SPINK1 | Hereditary Pancreatitis | ||||||||||||
| SQSTM1 | ||||||||||||||
| STK11 | STK11 | STK11 | STK11 | STK11 | STK11 | STK11 | Peutz-Jeghers Sydrome | |||||||
| TMEM127 | TMEM127 | TMEM127 | Pheochromocytoma | |||||||||||
| TP53 | TP53 | TP53 | TP53 | TP53 | TP53 | TP53 | TP53 | TP53 | TP53 | Colorectal cancer, Li-Fraumeni syndrome, Ependymoma, intracranial, Choroid plexus papilloma, Breast cancer, familial, Adrenocortical carcinoma, Osteogenic sarcoma, Hepatoblastoma, Non-Hodgkin lymphoma | ||||
| TRIM28 | TRIM28 | TRIM28 | Wilms Tumor | |||||||||||
| TSC1 | TSC1 | TSC1 | TSC1 | Tuberous sclerosis | ||||||||||
| TSC2 | TSC2 | TSC2 | TSC2 | Tuberous sclerosis | ||||||||||
| VHL | VHL | VHL | Pheochromocytoma, Von Hippel-Lindau disease | |||||||||||
| WT1 | WT1 | WT1 | Wilms tumor | |||||||||||
| XRCC2 | XRCC2 | Fanconi anemia, Breast cancer |